T細胞在支氣管哮喘并抑郁發病機制中的作用_《華西醫學》

作者：

何敏 , 王婷 ,  姬郁林

四川大學華西醫院呼吸內科（成都，610041）;

關鍵詞：

哮喘抑郁 T淋巴細胞病因學

DOI：

CNKI: 51-1356/R.20120214.1341.018

視頻：

導出 下載 收藏 掃碼 引用

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

支氣管哮喘與抑郁存在較高的共病率，T細胞對支氣管哮喘與抑郁的免疫調節作用及細胞因子與支氣管哮喘、抑郁間的病因學關系提示：支氣管哮喘與抑郁可能具有部分交叉的病因學機制，哮喘患者合并負性心境狀態出現可能與哮喘炎癥過程T細胞調節失常及復雜的細胞因子網絡有關。對相應T細胞在支氣管哮喘伴抑郁發病機制中的作用作一綜述，以深入探討支氣管哮喘并抑郁的發病機制。

引用本文： 何敏,王婷,姬郁林. T細胞在支氣管哮喘并抑郁發病機制中的作用. 華西醫學, 2012, 27(2): 294-299. doi: CNKI: 51-1356/R.20120214.1341.018 復制

1.	The Global Initiative for Asthma. Global strategy for asthma management and prevention[R/IOL]. (2011-03-39)[2011-12-01]. http://www.ginasthma.org/guildline-report-2010.html.
2.	Masoli M, Fabian D, Holt S, et al. Global burden of asthma[R/OL]. (2004-05-04)[2011-12-01].Global initiative for Asthma(GINA). http://www.ginasthma.org/pdf/GINABurderReport. pdf.
3.	Scott KM, Von Korff M, Ormel J, et al. Mental disorders among adults with asthma: results from the World Mental Health Survey[J]. Gen Hosp Psychiatry, 2007, 29(2): 123-133.
4.	Goodwin RD, Castro M, Kovacs M. Major depression and allergy: does neuroticism explain the relationship?[J]. Psychosom Med, 2006, 68(1): 94-98.
5.	Van Lieshout RJ, Bienenstock J, MacQueen GM. A review of candidate pathways underlying the association between asthma and major depressive disorder[J]. Psychosom Med, 2009, 71(2): 187-195.
6.	Robinson DS. The role of the T cell in asthma[J]. J Allergy Clin Immunol, 2010, 126(6): 1081-1093.
7.	Chung KF, Barnes PJ. Cytokines in asthma[J]. Thorax, 1999, 54(9): 825-857.
8.	American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR)[M/OL]. Arlington: American Psychiatric Association 2000. http://www.psych.org.
9.	Irwin MR, Miller AH. Depressive disorders and immunity: 20 years of progress and discovery[J]. Brain Behav Immun, 2007, 21(4): 374-383.
10.	Lavoie KL, Bacon SL, Barone S, et al. What is worse for asthma control and quality of life: depressive disorders, anxiety disorders, or both?[J]. Chest, 2006, 130(4): 1039-1047.
11.	王嵐, 莫祖聰, 姬郁林. 負面心境狀態與支氣管哮喘控制水平及其生活質量的相關性研究[J]. 四川大學學報(醫學版), 2009, 40(3): 544-547.
12.	Bender BG. Risk taking, depression, adherence, and symptom control in adolescents and young adults with asthma[J]. Am J Respir Crit Care Med, 2006, 173(9): 953-957.
13.	Wamboldt MZ, Hewitt JK, Schmitz S, et al. Familial association between allergic disorders and depression in adult Finnish twins[J]. Am J Med Genet, 2000, 96(2): 146-153.
14.	Wright RJ, Cohen R, Cohen S. The impact of stress on the development and expression of atopy[J]. Curr Opin Allergy Cl, 2005, 5(1): 23-29.
15.	Humbert M, Durham SR, Ying S, et al. IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against ‘‘intrinsic’’ asthma being a distinct immunopathologic entity[J]. Am J Resp Crit Care, 1996, 154(5): 1497-1504.
16.	Moner R, Mikova O, Koutsilieri E, et al. Consensus paper of the WFSBP task force on biological markers: biological markers in depression[J]. World J Biol Psychia, 2007, 8(3): 141-174.
17.	Zorrilla EP, Luborsky L, McKay JR, et al. The relationship of depression and stressors to immunological assays: a meta-analytic review[J]. Brain Behav Immun, 2001, 15(3): 199-226.
18.	Miller AH. Depression and immunity: a role for T cells?[J]. Brain Behav Immun, 2010, 24(1): 1-8.
19.	Myint AM, Leonard BE, Steinbusch HWM et al. Th1, Th2, and Th3 cytokine alterations in major depression[J]. J Affect Disorders, 2005, 88(2): 167-173.
20.	Kim YK, Na KS, Shin KH, et al. Cytokine imbalance in the pathophysiology of major depressive disorder[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2007, 31(5): 1044-1053.
21.	Hernandez ME, Mendieta D, Martinez-Fong D, et al. Variations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorder[J]. Eur Neuropsychopharm, 2008, 18(12): 917-924.
22.	Musselman DL, Lawson DH, Gumnick JF, et al. Paroxetine for the prevention of depression induced by high-dose interferon alfa[J]. New Engl J Med. 2001, 344(13): 961-966.
23.	Dantzer R, O’Connor JC, Freund GG, et al. From inflammation to sickness and depression: when the immune system subjugates the brain[J]. Nat Rev Neurosci, 2008, 9(1): 46-57.
24.	Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis[J]. Psychosom Med, 2009, 71(2): 171-186.
25.	Dowlati Y, Herrmann N, Swardfager W, et al. A Meta-analysis of cytokines in major depression[J]. Biological Psychiatry, 2010, 67(5): 446-457.
26.	Kimura A, Kishimoto T. IL-6: regulator of Treg/Th17 balance[J]. Eur J Immunol, 2010, 40(7): 1830-1835.
27.	Kishimoto T. IL-6: from its discovery to clinical applications[J]. Int Immunol, 2010, 22(5): 347-352.
28.	Maes M, Scharpe S, Meltzer HY, et al. Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression[J]. Psychiat Res, 1993, 49(1): 11-27.
29.	Levine J, Barak Y, Chengappa KN, et al. Cerebrospinal cytokine levels in patients with acute depression[J]. Neuropsychobiology, 1999, 40(4): 171-176.
30.	Bluthe RM, Michaud B, Poli V, et al. Role of IL-6 in cytokine-induced sickness behavior: a study with IL-6 deficient mice[J]. Physiol Behav, 2000, 70(3-4): 367-373.
31.	Berry MA, Hargadon B, Shelley M, et al. Evidence of a role of tumor necrosis factor alpha in refractory asthma[J]. New Engl J Med, 2006, 354(7): 697-708.
32.	Ying S, Robinson DS, Varney V, et al. TNF alpha mRNA expression in allergic inflammation[J]. Clin Exp Allergy, 1991, 21(6): 745-750.
33.	Thomas PS, Yates DH, Barnes PJ. Tumor necrosis factor-alpha increases airway responsiveness and sputum neutrophilia in normal human subjects[J]. Am J Resp Crit Care, 1995, 152(1): 76-80.
34.	Thomas PS, Heywood G. Effects of inhaled tumour necrosis factor alpha in subjects with mild asthma[J]. Thorax, 2002, 57(9): 774-778.
35.	Desai D, Brightling C. Cytokine and anti-cytokine therapy in asthma: ready for the clinic?[J]. Clin Exp Immunol, 2009, 158(1): 10-19.
36.	Simen BB, Duman CH, Simen AA, et al. TNFalpha signaling in depression and anxiety: behavioral consequences of individual receptor targeting[J]. Biol Psychiat, 2006, 59(9): 775-785.
37.	Bochner BS, Luscinskas FW, Gimbrone MA, et al. Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules[J]. J Exp Med, 1991, 173(6): 1553-1557.
38.	Barrientos RM, Sprunger DB, Campeau S, et al. Brain-derived neurotrophic factor mRNA downregulation produced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist[J]. Neuroscience, 2003, 121(4): 847-853.
39.	Goshen I, Kreisel T, Ben-Menachem-Zidon O, et al. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression[J]. Mol Psychiatr, 2008, 13(7): 717-728.
40.	Pavon L, Sandoval-Lopez G, Hernandez ME, et al. Th2 cytokine response in Major Depressive Disorder patients before treatment[J]. J Neuroimmunol, 2006, 172(1-2): 156-165.
41.	Hartl D, Koller B, Mehlhorn AT, et al. Quantitative and functional impairment of pulmonary CD4+ CD25hi regulatory T cells in pediatric asthma[J]. J Allergy Clin Immun, 2007, 119(5): 1258-1266.
42.	Li Y, Xiao B, Qiu WJ, et al. Altered expression of CD4+ CD25+regulatory T cells and its 5-HT1a receptor in patients with major depression disorder[J]. J Affect Disorders, 2010, 124(1-2): 68-75.
43.	Himmerich H, Milenovic S, Fulda S, et al. Regulatory T cells increased while IL-1beta decreased during antidepressant therapy[J]. J Psychiatr Res, 2010, 44(15): 1052-1057.

1. 　The Global Initiative for Asthma. Global strategy for asthma management and prevention[R/IOL]. (2011-03-39)[2011-12-01]. http://www.ginasthma.org/guildline-report-2010.html.
2. 　Masoli M, Fabian D, Holt S, et al. Global burden of asthma[R/OL]. (2004-05-04)[2011-12-01].Global initiative for Asthma(GINA). http://www.ginasthma.org/pdf/GINABurderReport. pdf.
3. 　Scott KM, Von Korff M, Ormel J, et al. Mental disorders among adults with asthma: results from the World Mental Health Survey[J]. Gen Hosp Psychiatry, 2007, 29(2): 123-133.
4. 　Goodwin RD, Castro M, Kovacs M. Major depression and allergy: does neuroticism explain the relationship?[J]. Psychosom Med, 2006, 68(1): 94-98.
5. 　Van Lieshout RJ, Bienenstock J, MacQueen GM. A review of candidate pathways underlying the association between asthma and major depressive disorder[J]. Psychosom Med, 2009, 71(2): 187-195.
6. 　Robinson DS. The role of the T cell in asthma[J]. J Allergy Clin Immunol, 2010, 126(6): 1081-1093.
7. 　Chung KF, Barnes PJ. Cytokines in asthma[J]. Thorax, 1999, 54(9): 825-857.
8. 　American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR)[M/OL]. Arlington: American Psychiatric Association 2000. http://www.psych.org.
9. 　Irwin MR, Miller AH. Depressive disorders and immunity: 20 years of progress and discovery[J]. Brain Behav Immun, 2007, 21(4): 374-383.
10. 　Lavoie KL, Bacon SL, Barone S, et al. What is worse for asthma control and quality of life: depressive disorders, anxiety disorders, or both?[J]. Chest, 2006, 130(4): 1039-1047.
11. 　王嵐, 莫祖聰, 姬郁林. 負面心境狀態與支氣管哮喘控制水平及其生活質量的相關性研究[J]. 四川大學學報(醫學版), 2009, 40(3): 544-547.
12. 　Bender BG. Risk taking, depression, adherence, and symptom control in adolescents and young adults with asthma[J]. Am J Respir Crit Care Med, 2006, 173(9): 953-957.
13. 　Wamboldt MZ, Hewitt JK, Schmitz S, et al. Familial association between allergic disorders and depression in adult Finnish twins[J]. Am J Med Genet, 2000, 96(2): 146-153.
14. 　Wright RJ, Cohen R, Cohen S. The impact of stress on the development and expression of atopy[J]. Curr Opin Allergy Cl, 2005, 5(1): 23-29.
15. 　Humbert M, Durham SR, Ying S, et al. IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against ‘‘intrinsic’’ asthma being a distinct immunopathologic entity[J]. Am J Resp Crit Care, 1996, 154(5): 1497-1504.
16. 　Moner R, Mikova O, Koutsilieri E, et al. Consensus paper of the WFSBP task force on biological markers: biological markers in depression[J]. World J Biol Psychia, 2007, 8(3): 141-174.
17. 　Zorrilla EP, Luborsky L, McKay JR, et al. The relationship of depression and stressors to immunological assays: a meta-analytic review[J]. Brain Behav Immun, 2001, 15(3): 199-226.
18. 　Miller AH. Depression and immunity: a role for T cells?[J]. Brain Behav Immun, 2010, 24(1): 1-8.
19. 　Myint AM, Leonard BE, Steinbusch HWM et al. Th1, Th2, and Th3 cytokine alterations in major depression[J]. J Affect Disorders, 2005, 88(2): 167-173.
20. 　Kim YK, Na KS, Shin KH, et al. Cytokine imbalance in the pathophysiology of major depressive disorder[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2007, 31(5): 1044-1053.
21. 　Hernandez ME, Mendieta D, Martinez-Fong D, et al. Variations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorder[J]. Eur Neuropsychopharm, 2008, 18(12): 917-924.
22. 　Musselman DL, Lawson DH, Gumnick JF, et al. Paroxetine for the prevention of depression induced by high-dose interferon alfa[J]. New Engl J Med. 2001, 344(13): 961-966.
23. 　Dantzer R, O’Connor JC, Freund GG, et al. From inflammation to sickness and depression: when the immune system subjugates the brain[J]. Nat Rev Neurosci, 2008, 9(1): 46-57.
24. 　Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis[J]. Psychosom Med, 2009, 71(2): 171-186.
25. 　Dowlati Y, Herrmann N, Swardfager W, et al. A Meta-analysis of cytokines in major depression[J]. Biological Psychiatry, 2010, 67(5): 446-457.
26. 　Kimura A, Kishimoto T. IL-6: regulator of Treg/Th17 balance[J]. Eur J Immunol, 2010, 40(7): 1830-1835.
27. 　Kishimoto T. IL-6: from its discovery to clinical applications[J]. Int Immunol, 2010, 22(5): 347-352.
28. 　Maes M, Scharpe S, Meltzer HY, et al. Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression[J]. Psychiat Res, 1993, 49(1): 11-27.
29. 　Levine J, Barak Y, Chengappa KN, et al. Cerebrospinal cytokine levels in patients with acute depression[J]. Neuropsychobiology, 1999, 40(4): 171-176.
30. 　Bluthe RM, Michaud B, Poli V, et al. Role of IL-6 in cytokine-induced sickness behavior: a study with IL-6 deficient mice[J]. Physiol Behav, 2000, 70(3-4): 367-373.
31. 　Berry MA, Hargadon B, Shelley M, et al. Evidence of a role of tumor necrosis factor alpha in refractory asthma[J]. New Engl J Med, 2006, 354(7): 697-708.
32. 　Ying S, Robinson DS, Varney V, et al. TNF alpha mRNA expression in allergic inflammation[J]. Clin Exp Allergy, 1991, 21(6): 745-750.
33. 　Thomas PS, Yates DH, Barnes PJ. Tumor necrosis factor-alpha increases airway responsiveness and sputum neutrophilia in normal human subjects[J]. Am J Resp Crit Care, 1995, 152(1): 76-80.
34. 　Thomas PS, Heywood G. Effects of inhaled tumour necrosis factor alpha in subjects with mild asthma[J]. Thorax, 2002, 57(9): 774-778.
35. 　Desai D, Brightling C. Cytokine and anti-cytokine therapy in asthma: ready for the clinic?[J]. Clin Exp Immunol, 2009, 158(1): 10-19.
36. 　Simen BB, Duman CH, Simen AA, et al. TNFalpha signaling in depression and anxiety: behavioral consequences of individual receptor targeting[J]. Biol Psychiat, 2006, 59(9): 775-785.
37. 　Bochner BS, Luscinskas FW, Gimbrone MA, et al. Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules[J]. J Exp Med, 1991, 173(6): 1553-1557.
38. 　Barrientos RM, Sprunger DB, Campeau S, et al. Brain-derived neurotrophic factor mRNA downregulation produced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist[J]. Neuroscience, 2003, 121(4): 847-853.
39. 　Goshen I, Kreisel T, Ben-Menachem-Zidon O, et al. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression[J]. Mol Psychiatr, 2008, 13(7): 717-728.
40. 　Pavon L, Sandoval-Lopez G, Hernandez ME, et al. Th2 cytokine response in Major Depressive Disorder patients before treatment[J]. J Neuroimmunol, 2006, 172(1-2): 156-165.
41. 　Hartl D, Koller B, Mehlhorn AT, et al. Quantitative and functional impairment of pulmonary CD4+ CD25hi regulatory T cells in pediatric asthma[J]. J Allergy Clin Immun, 2007, 119(5): 1258-1266.
42. 　Li Y, Xiao B, Qiu WJ, et al. Altered expression of CD4+ CD25+regulatory T cells and its 5-HT1a receptor in patients with major depression disorder[J]. J Affect Disorders, 2010, 124(1-2): 68-75.
43. 　Himmerich H, Milenovic S, Fulda S, et al. Regulatory T cells increased while IL-1beta decreased during antidepressant therapy[J]. J Psychiatr Res, 2010, 44(15): 1052-1057.

上一篇
護士標準化病人在精神專科護士培訓中的應用
下一篇
特發性肺含鐵血黃素沉著癥一例

《華西醫學》

T細胞在支氣管哮喘并抑郁發病機制中的作用

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

上一篇

下一篇

Format

Content

《華西醫學》

T細胞在支氣管哮喘并抑郁發病機制中的作用

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

上一篇

下一篇

Format

Content

摘要全文圖表視頻參考文獻施引文獻補充材料